[1] F. H. Ng, K. S. Yung, and W. H. Luk, “Ectopic Submandibular Parathyroid Adenoma by Tc-99m Sestamibi SPECT/CT Localization,” J. Clin. Imaging Sci., vol. 10, 2020,
DOI: 10.25259/JCIS_125_2020
[2] J. C. Lee, H. Mazeh, J. Serpell, L. W. Delbridge, H. Chen, and S. Sidhu, “Adenomas of cervical maldescended parathyroid glands: Pearls and pitfalls,” ANZ J. Surg., vol. 85, no. 12, pp. 957–961, Dec. 2015,
DOI: 10.1111/ans.12017
[3] A. Adarve Castro, D. Domínguez Pinos, V. Soria Utrilla, J. A. O’Farrell del Campo, F. Sendra Portero, and M. J. Ruiz-Gómez, “Update in imaging tests used for the localization of parathyroid pathology,” Radiologia, vol. 66, no. 3, pp. 236–247, May 2024,
DOI: 10.1016/j.rxeng.2023.04.006
[4] S. Mahajan and H. Schoder, “Ectopic Avoids Undescended False-Negative Parathyroid Interpretation Adenoma on 99m — Tc-MIBI SPECT/CT Dual-Phase Scintigraphy,” Clin. Nucl. Med., vol. 43, no. 3, pp. 199–200, Mar. 2018,
DOI: 10.1097/RLU.0000000000001958
[5] G. Cacciatore et al., “How has the diagnostic approach to parathyroid localization techniques evolved in the past decade? Insights from a single-center experience,” Updates Surg., vol. 77, no. 2, Apr. 2025,
DOI: 10.1007/s13304-025-02090-8
[6] D. Axelrod, J. C. Sisson, K. Cho, J. Miskulin, and P. G. Gauger, “Appearance of Ectopic Undescended Inferior Parathyroid Adenomas on Technetium Tc 99m Sestamibi Scintigraphy: A Lesson From Reoperative Parathyroidectomy,” Arch. Surg., vol. 138, no. 11, pp. 1214–1218, Nov. 2003,
DOI: 10.1001/archsurg.138.11.1214
[7] А. Е. А et al., “Aboisheva EA, Avsievich ES, Korchagina MO, Degtyarev MV, Bibik EE, Beltsevich DG, Pigarova EA, Sheremeta MS. [Management of primary hyperparathyroidism with rare localization of ectopic adenoma parathyroid gland]. Probl Endokrinol (Mosk). 2024 Apr 1;71(1),” Probl. Endocrinol., vol. 71, no. 1, p. 20, 2024,
DOI: 10.14341/probl13425
[8] N. Chakrabarty, A. Mahajan, S. Basu, and A. K. D’Cruz, “Imaging Recommendations for Diagnosis and Management of Primary Parathyroid Pathologies: A Comprehensive Review,” Cancers (Basel)., vol. 16, no. 14, p. 2593, Jul. 2024,
DOI: 10.3390/cancers16142593
[9] J. P. Bilezikian et al., “Evaluation and Management of Primary Hyperparathyroidism: Summary Statement and Guidelines from the Fifth International Workshop,” J. Bone Miner. Res., vol. 37, no. 11, pp. 2293–2314, Nov. 2022,
[10] S. M. Wilhelm et al., “The American Association of Endocrine Surgeons Guidelines for Definitive Management of Primary Hyperparathyroidism,” JAMA Surg., vol. 151, no. 10, pp. 959–968, Oct. 2016,
DOI: 10.1001/jamasurg.2016.2310
[11] C. Y. Zhu, C. Sturgeon, and M. W. Yeh, “Diagnosis and Management of Primary Hyperparathyroidism,” JAMA, vol. 323, no. 12, pp. 1186–1187, Mar. 2020,
DOI: 10.1001/jama.2020.0538
[12] J. P. Bilezikian et al., “Guidelines for the Management of Asymptomatic Primary Hyperparathyroidism: Summary Statement from the Fourth International Workshop,” J. Clin. Endocrinol. Metab., vol. 99, no. 10, pp. 3561–3569, Oct. 2014,
DOI: 10.1210/jc.2014-1413
[13] D. M. Simeone, K. Sandelin, and N. W. Thompson, “Undescended superior parathyroid gland: A potential cause of failed cervical exploration for hyperparathyroidism,” Surgery, vol. 118, no. 6, pp. 949–956, 1995,
DOI: 10.1016/S0039-6060(05)80099-6
[14] T. M Unais, P. Gangadhar, and N. Kolikkat, “Acute hyperparathyroid crisis: Ectopic submandibular parathyroid gland the culprit,” Ann. R. Coll. Surg. Engl., vol. 103, no. 1, pp. E7–E9, Jan. 2021,
DOI: 10.1308/rcsann.2020.0183
[15] V. G. Calcutt, R. Franco-Saenz, L. B. Morrow, and P. J. Mulrow, “Localization of Abnormal Parathyroid Tissue With Use of Technetium-99m-Sestamibi,” Endocr. Pract., vol. 4, no. 4, pp. 184–189, Jul. 1998,
DOI: 10.4158/EP.4.4.184
[16] M. E. Noltes et al., “A retrospective analysis of the diagnostic performance of 11C-choline PET/CT for detection of hyperfunctioning parathyroid glands after prior negative or discordant imaging in primary hyperparathyroidism,” EJNMMI Res., vol. 11, no. 1, 2021,
DOI: 10.1186/s13550-021-00778-7
[17] S. B. Ferrari et al., “Clinical predictors of negative/equivocal SPECT imaging outcomes in primary hyperparathyroidism: Factors calling for 18F-choline-PET,” Am. J. Otolaryngol. - Head Neck Med. Surg., vol. 45, no. 4, Jul. 2024,
DOI: 10.1016/j.amjoto.2024.104315
[18] N. Thanseer et al., “Comparative Effectiveness of Ultrasonography, 99mTc-Sestamibi, and 18F-Fluorocholine PET/CT in Detecting Parathyroid Adenomas in Patients With Primary Hyperparathyroidism,” Clin. Nucl. Med., vol. 42, no. 12, pp. E491–E497, Dec. 2017,
DOI: 10.1097/RLU.0000000000001845
[19] L. Yi, S. Yuling, and Z. Jiaqing, “99Tcm-MIBI SPECT/CT negative ectopic parathyroid adenoma in submandibular region: a case report,” Chinese J. Otorhinolaryngol. Head Neck Surg., vol. 58, no. 2, pp. 157–159, Feb. 2023,
[20] G. Treglia et al., “Diagnostic performance of choline PET for detection of hyperfunctioning parathyroid glands in hyperparathyroidism: a systematic review and meta-analysis,” Eur. J. Nucl. Med. Mol. Imaging, vol. 46, no. 3, pp. 751–765, Mar. 2019,
DOI: 10.1007/s00259-018-4123-z
[21] E. Quak et al., “F18-choline PET/CT guided surgery in primary hyperparathyroidism when ultrasound and MIBI SPECT/CT are negative or inconclusive: the APACH1 study,” Eur. J. Nucl. Med. Mol. Imaging, vol. 45, no. 4, pp. 658–666, Apr. 2018,
DOI: 10.1007/s00259-017-3911-1
[22] M. Wiedmann, W. Kassahun, F. Deckert, M. Tröltzsch, M. Sturmvoll, and D. Führer, “65-Jährige patientin mit persistierender hyperkalzämie,” Internist, vol. 48, no. 12, pp. 1436–1441, Dec. 2007,
DOI: 10.1007/s00108-007-1957-z
[23] M. S. Rajagopalan, V. V. Narla, T. Kanderi, and A. Muthukrishnan, “Para-hyoid ectopic parathyroid adenoma localized by Tc-99m MIBI SPECT,” Clin. Nucl. Med., vol. 33, no. 12, pp. 880–881, Dec. 2008,
DOI: 10.1097/RLU.0b013e31818bf36d
[24] L. S. Serchuk, M. B. Tomas, M. Patel, and C. J. Palestro, “SPECT and subtraction imaging of an ectopic parathyroid adenoma,” Clin. Nucl. Med., vol. 22, no. 7, pp. 459–462, 1997,
DOI: 10.1097/00003072-199707000-00002
[25] Y. Kong, S. Y. Ge, W. Shang, and K. Song, “Ectopic parathyroid adenoma in the submandibular region: a case report,” Br. J. Oral Maxillofac. Surg., vol. 57, no. 10, pp. 1150–1152, Dec. 2019,
DOI: 10.1016/j.bjoms.2019.10.296
[26] Y. Edamadaka, G. Malhotra, A. Daga, S. S. Memon, A. R. Lila, and T. Bandgar, “Multimodality Evaluation of Persistent Hyperparathyroidism in a Rare Case of Ectopic Submandibular Parathyroid Adenoma,” Clin. Nucl. Med., vol. 49, no. 12, pp. e670–e673, Dec. 2024,
DOI: 10.1097/RLU.0000000000005495
[27] J. A. Hakim Tawil, A. Flórez, M. C. Sanabria, M. Palau, and J. J. Santivañez, “Submandibular Ectopic Parathyroid Adenoma: A Case Report,” Ear, Nose Throat J., 2023,
DOI: 10.1177/01455613231177193